Name: PRDX1 | Sequence: fasta or formatted (199aa) | NCBI GI: 32455264 | |
Description: peroxiredoxin 1
|
Referenced in:
| ||
Other entries for this name:
alt mRNA [199aa] peroxiredoxin 1 alt mRNA [199aa] peroxiredoxin 1 | |||
Composition:
Amino acid Percentage Count Longest homopolymer A alanine 6.0 12 1 C cysteine 2.0 4 1 D aspartate 8.0 16 2 E glutamate 3.5 7 2 F phenylalanine 7.5 15 3 G glycine 8.0 16 2 H histidine 2.0 4 1 I isoleucine 6.5 13 2 K lysine 9.5 19 2 L leucine 6.0 12 1 M methionine 1.5 3 1 N asparagine 3.0 6 1 P proline 6.5 13 1 Q glutamine 4.5 9 1 R arginine 3.0 6 1 S serine 6.5 13 2 T threonine 4.5 9 1 V valine 7.5 15 2 W tryptophan 1.0 2 1 Y tyrosine 2.5 5 1 |
Comparative genomics:
Search single species RefSeq proteins at NCBI
Search summary
Figure data | ||
Related human proteins:Protein Relative score Description Self-match 1.000 peroxiredoxin 1 PRDX1 1.000 peroxiredoxin 1 PRDX1 1.000 peroxiredoxin 1 PRDX2 0.793 peroxiredoxin 2 isoform a PRDX4 0.677 peroxiredoxin 4 PRDX3 0.618 peroxiredoxin 3 isoform a precursor PRDX3 0.618 peroxiredoxin 3 isoform b LOC100292021 0.434 PREDICTED: similar to thioredoxin peroxidase PRDX2 0.310 peroxiredoxin 2 isoform c PRDX6 0.142 peroxiredoxin 6 LOC100133641 0.026 PREDICTED: similar to peroxiredoxin 6 NPY1R 0.013 neuropeptide Y receptor Y1 HDGF 0.008 hepatoma-derived growth factor isoform c HDGF 0.008 hepatoma-derived growth factor isoform b HDGF 0.008 hepatoma-derived growth factor isoform a KIAA1432 0.008 connexin 43-interacting protein 150 isoform aHuman BLASTP results (used to prepare the table) |
Gene descriptions are from NCBI RefSeq. Search results were obtained with NCBI BLAST and RefSeq entries. When identical proteins are present, the self-match may not be listed first in BLASTP output. In such cases, the table above has been reordered to place it first.
See About the Figures for the scoring system used in the figure above right. The same scoring system was used in the table of BLASTP results.
Guide to the Human Genome
Copyright © 2010 by Stewart Scherer. All rights reserved.